Background
A significant clinicopathological and genetic overlap has been suggested between amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD).
Aim
To determine the overlap, we assessed the cerebral atrophy as a surrogate indicator of FTLD in ALS inpatients with post‐tracheostomy positive pressure ventilation by CT imaging analysis.
Methods
The extent of cerebral atrophy was quantitatively evaluated in 92 ALS patients (age: 68.3 ± 11.0 years and disease duration: 7.6 ± 4.8 years) and 42 age‐matched healthy controls (age: 60.4 ± 13.6 years) by computer‐mediated assessments of sizes of the following four areas [anterior temporal (TL), frontal lobes (FL), and inferior horn (IH) and anterior horn (AH) of the lateral ventricle] and of the corresponding intracranial fossae, to minimize individual head‐size differences.
Results
More than half of the ALS patients clearly exhibited the parenchymal atrophy in TL and FL regions and the ventricular dilatation in IH and AH areas, both of which exceed the age‐associated physiological changes. By clustering analysis using degrees of TL and FL atrophy and of IH and AH dilatation the ALS patients examined were grouped into five clusters resulting in the following characteristics: (i) normal to mild frontotemporal cortical atrophy (51%); (ii) mild frontotemporal lobar atrophy (FTLA) (26%); (iii) moderate FTLA (15%); (iv) severe FTLA (4%); and (v) severe temporal lobar atrophy (3%).
Conclusion
Half of the ALS patients after ventilation had apparent frontotemporal lobar atrophy by CT imaging, and such patients would develop FTLD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.